Based on the important role of the JAK2‐STAT3 signaling pathway, we investigated the molecular mechanism of action of tapinarof and demonstrated that tapinarof could inhibit Tfh cells development through the JAK2‐STAT3 signaling pathway to alleviate lupus symptoms in MRL/lpr mice. This evidence concerns the gene JAK2 and systemic lupus erythematosus.